Myriad Genetics
MYGN
#7054
Rank
C$0.76 B
Marketcap
C$8.24
Share price
-1.99%
Change (1 day)
-54.07%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2025 (TTM): -C$0.58 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are C$0.82 Billion. In 2024 the company made an earning of -C$0.17 Billion, an increase over its 2023 earnings that were of -C$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.58 Billion242.76%
2024 -C$0.17 Billion-53.49%
2023 -C$0.37 Billion88.72%
2022 -C$0.2 Billion172.08%
2021 -C$70.28 Million
2019 -C$36.6 Million-175.14%
2018 C$48.7 M-70.81%
2017 C$0.16 B22.22%
2016 C$0.13 B-38.8%
2015 C$0.22 B-6.12%
2014 C$0.23 B-41.07%
2013 C$0.40 B46.67%
2012 C$0.27 B15.84%
2011 C$0.23 B17.6%
2010 C$0.20 B-15.96%
2009 C$0.24 B
2007 -C$58 Million40.96%
2006 -C$41.15 Million
2003 -C$47.78 Million34.8%
2002 -C$35.45 Million89.21%
2001 -C$18.74 Million3.93%
2000 -C$18.03 Million21.76%
1999 -C$14.81 Million-25.61%
1998 -C$19.9 Million38.83%
1997 -C$14.34 Million-24.26%
1996 -C$18.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Bio-Rad Laboratories
BIO
-C$1.18 Billion 101.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-C$1.35 Billion 131.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-C$48.66 Million-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.94 B-262.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.32 B-2,044.56%๐Ÿ‡บ๐Ÿ‡ธ USA